No (subjects with systolic blood plessure 130-159 mmHg and diastolic blood pressure 85-99 mmHg)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Volunteers with high-normal blood pressure (SBP 130-139mmHg, DBP 85-89mmHg) and mild hypertenssion (SBP 140-159mmHg, DBP 90-99mmHg). 2.Volunteers being able to make self-judgment to participate in this study and giving written informed consent. 3.Volunteers having screening test results judged to be appropriate for this study by investigator.
Exclusion criteria
Exclusion criteria: 1.Patients receiving treatment of hypertension. 2.SBP 160mmHg < ; DBP 100mmHg <. 3.Volunteers having severe history of the diseases (liver, kidney, heart, blood) judged to be inappropriate for this study. 4.Volunteers received gastrectomy, enterectomy, and gastro-intestinal dedeases, judged to be inappropriate for this study. 5.Volunteers rejected participating in this study by chief investigater.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chronological changes and comparison in blood pressure and flow mediated dilation levels among three different doses,(350ml/day extracted from 0, 4, 8g of the dried leaves, respectively). | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the optimum dose amount of persimmon leaf tea intake for the improvement. | — |
Countries
Japan
Contacts
Niigata Bio-Research Park, Inc Business promotion division